Cellosaurus 9F3.18.5 (CVCL_F1WG)
| Cell line name | 9F3.18.5 |
|---|---|
| Synonyms | 9F3 |
| Accession | CVCL_F1WG |
| Resource Identification Initiative | To cite this cell line use: 9F3.18.5 (RRID:CVCL_F1WG) |
| Comments | Group: Patented cell line. Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2917. Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized rontalizumab (9F3v13) therapeutic antibody which was designed to target and block the effects of interferon-alphain patients with autoimmune diseases like systemic lupus erythematosus (SLE). Monoclonal antibody isotype: Not specified. Monoclonal antibody target: Human alpha-interferons. |
| Species of origin | Mus musculus (Mouse) (NCBI Taxonomy: 10090) |
| Hierarchy | Parent: CVCL_3412 (P3X63Ag8U.1) |
| Category | Hybridoma |
| Publications | PubMed=11594789; DOI=10.1006/cyto.2001.0934 Patent=US8557967 |
| Cross-references | |
| Biological sample resources | ABCD; ABCD_BG479 |
| Entry history | |
| Entry creation | 27-Nov-2025 |
| Last entry update | 27-Nov-2025 |
| Version number | 1 |